These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10355931)

  • 1. Antiarrhythmic drugs and ion channels: have we made the connection?
    Carmeliet E
    J Cardiovasc Electrophysiol; 1999 May; 10(5):755-9. PubMed ID: 10355931
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac electrophysiological effects of nitric oxide.
    Tamargo J; Caballero R; Gómez R; Delpón E
    Cardiovasc Res; 2010 Sep; 87(4):593-600. PubMed ID: 20587506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["Sicilian gambit": pathophysiological approach to drug therapy of arrhythmia (lecture]].
    Sulimov VA
    Ter Arkh; 1999; 71(8):67-74. PubMed ID: 10515042
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current concepts of the ionic mechanisms of cardiac arrhythmias and the possible mechanisms of action of cardiac anti-arrhythmia agents].
    Porotikov VI; Lazarev AV; Glezer GA
    Usp Fiziol Nauk; 1984; 15(3):42-63. PubMed ID: 6089463
    [No Abstract]   [Full Text] [Related]  

  • 5. [The working classification of antiarrhythmic drugs based on the pathogenetic approach to treatment of cardiac arrhythmias].
    Lipnitskiĭ TN; Kozlovskiĭ VA
    Lik Sprava; 2002; (8):26-30. PubMed ID: 12669534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic agents: current status and perspectives.
    Mátyus P; Varró A; Papp JG; Wamhoff H; Varga I; Virág L
    Med Res Rev; 1997 Sep; 17(5):427-51. PubMed ID: 9276860
    [No Abstract]   [Full Text] [Related]  

  • 7. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modernized Classification of Cardiac Antiarrhythmic Drugs.
    Lei M; Wu L; Terrar DA; Huang CL
    Circulation; 2018 Oct; 138(17):1879-1896. PubMed ID: 30354657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiac ion channels: relevance to management of arrhythmias.
    Roden DM; George AL
    Annu Rev Med; 1996; 47():135-48. PubMed ID: 8712768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cellular action of antiarrhythmic drugs.
    Gold MR; Balke CW
    Heart Dis Stroke; 1993; 2(5):434-8. PubMed ID: 7511029
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of action of antiarrhythmic drugs: from ion channel blockage to arrhythmia termination.
    Grant AO
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 2):432-44. PubMed ID: 9058847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular effects of anti-arrhythmia drugs. Their predictive value of therapeutic effects].
    Motté G
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():7-16. PubMed ID: 6280631
    [No Abstract]   [Full Text] [Related]  

  • 13. Selectivity and toxicity of antiarrhythmic drugs: molecular interactions with ion channels.
    Katz AM
    Am J Med; 1998 Feb; 104(2):179-95. PubMed ID: 9528738
    [No Abstract]   [Full Text] [Related]  

  • 14. Channel-specific therapy of cardiac arrhythmias in our time?
    Fozzard HA
    J Cardiovasc Electrophysiol; 2000 Mar; 11(3):369-70. PubMed ID: 10749361
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac arrhythmogenesis: a tale of two clocks?
    Lei M; Huang CL
    Cardiovasc Res; 2020 Dec; 116(14):e205-e209. PubMed ID: 31800017
    [No Abstract]   [Full Text] [Related]  

  • 16. German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management.
    Thomas D; Christ T; Fabritz L; Goette A; Hammwöhner M; Heijman J; Kockskämper J; Linz D; Odening KE; Schweizer PA; Wakili R; Voigt N
    Clin Res Cardiol; 2019 Jun; 108(6):577-599. PubMed ID: 30306295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Circulation; 1991 Oct; 84(4):1831-51. PubMed ID: 1717173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast and furious: new ways to think about, study and treat cardiac arrhythmias.
    Joyner MJ; Nattel S
    J Physiol; 2009 Apr; 587(Pt 7):1383-4. PubMed ID: 19336610
    [No Abstract]   [Full Text] [Related]  

  • 19. Current antiarrhythmic drugs: an overview of mechanisms of action and potential clinical utility.
    Singh BN
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):283-301. PubMed ID: 10090235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use-dependent modulation of myocardial conduction by a new class of HERG agonists: deal breaker or cherry on top?
    Akar FG
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):930-2. PubMed ID: 20367661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.